Highlights of dry eye Phase 2 clinical study revealed

October 7, 2010

Article

ISTA Pharmaceuticals has highlighted results from its Phase 2 clinical study on Remura dry eye solution.

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!

Related Content

A hand writes a check mark in a box. It is superimposed over an image of samples in a laboratory. Image credit: ©everythingpossible – stock.adobe.com

European Commission grants marketing authorisation to aflibercept biosimilar EYLUXVI (ALT-L9)

Martin David Harp

September 18th 2025

Article

Higher Molar Dose and Its Translation into Clinical Practice

John Kitchens, MD;Peter Kaiser, MD

September 18th 2025

Podcast

$An image of an iris placed over a digital interlay. Concept image for BVI Medical and VirtuaLens new technologies at European Society of Cataract and Refractive Surgeons meeting in Copenhagen, Denmark. (Image credit: ©spainter_vfx/AdobeStock)$